Cargando…

A 14-gene gemcitabine resistance gene signature is significantly associated with the prognosis of pancreatic cancer patients

To identify a gemcitabine resistance-associated gene signature for risk stratification and prognosis prediction in pancreatic cancer. Pearson correlation analysis was performed with gemcitabine half maximal inhibitory concentration (IC50) data of 17 primary pancreatic cancer lines from Genomics of D...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Xing, Zhou, Xiaochong, Zhao, Yun, He, Yang, Weng, Zhen, Xu, Chunfang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969955/ https://www.ncbi.nlm.nih.gov/pubmed/33731794 http://dx.doi.org/10.1038/s41598-021-85680-x

Ejemplares similares

The relationship between Helicobacter pylori and pancreatic cancer: a meta-analysis
por: Xu, Wei, et al.
Publicado: (2022)

An Inflammatory Response Related Gene Signature Associated with Survival Outcome and Gemcitabine Response in Patients with Pancreatic Ductal Adenocarcinoma
por: Xiao, Zhijun, et al.
Publicado: (2021)

Circular RNA Signature Predicts Gemcitabine Resistance of Pancreatic Ductal Adenocarcinoma
por: Shao, Feng, et al.
Publicado: (2018)

Signature of gene aberrant alternative splicing events in pancreatic adenocarcinoma prognosis
por: Yao, Jun, et al.
Publicado: (2021)

An Efficient Signature Based on Necroptosis-Related Genes for Prognosis of Patients With Pancreatic Cancer
por: Shi, Heng, et al.
Publicado: (2022)

Inhibitory effect of metformin combined with gemcitabine on pancreatic cancer cells in vitro and in vivo
por: Shi, Yuqi, et al.
Publicado: (2016)

The role of ferroptosis regulators in the prognosis, immune activity and gemcitabine resistance of pancreatic cancer
por: Tang, Rong, et al.
Publicado: (2020)

Oncogenic ADAM28 induces gemcitabine resistance and predicts a poor prognosis in pancreatic cancer
por: Wei, Li, et al.
Publicado: (2019)

Single-cell RNA sequencing revealed subclonal heterogeneity and gene signatures of gemcitabine sensitivity in pancreatic cancer
por: Hou, Zelin, et al.
Publicado: (2023)

Gene signature associated with neuro‐endocrine activity predicting prognosis of pancreatic carcinoma
por: Chen, Ke, et al.
Publicado: (2019)

Ferroptosis: At the Crossroad of Gemcitabine Resistance and Tumorigenesis in Pancreatic Cancer
por: Yang, Jianhui, et al.
Publicado: (2021)

Genomic relevance of FGF14 and associated genes on the prognosis of pancreatic cancer
por: Raja, Aroosha, et al.
Publicado: (2021)

Reduced expression of phosphorylated ataxia-telangiectasia mutated gene is related to poor prognosis and gemcitabine chemoresistance in pancreatic cancer
por: Xun, Jingyu, et al.
Publicado: (2023)

PAC-5 Gene Expression Signature for Predicting Prognosis of Patients with Pancreatic Adenocarcinoma
por: Kim, Jieun, et al.
Publicado: (2019)

Genome-Wide CRISPR Screening Identifies DCK and CCNL1 as Genes That Contribute to Gemcitabine Resistance in Pancreatic Cancer
por: Yang, Hai, et al.
Publicado: (2022)

Prognosis and Immunotherapy Significances of a Cancer-Associated Fibroblasts-Related Gene Signature in Gliomas
por: Chen, Zhimin, et al.
Publicado: (2021)

Pan-cancer analysis of necroptosis-related gene signature for the identification of prognosis and immune significance
por: Ma, Jincheng, et al.
Publicado: (2022)

The value of a metabolic reprogramming-related gene signature for pancreatic adenocarcinoma prognosis prediction
por: Tan, Zhen, et al.
Publicado: (2020)

A Novel Cuproptosis-Associated Gene Signature to Predict Prognosis in Patients with Pancreatic Cancer
por: Du, Yan, et al.
Publicado: (2023)

Novel necroptosis-related gene signature for predicting the prognosis of pancreatic adenocarcinoma
por: Wu, Zixuan, et al.
Publicado: (2022)

The prognostic value and clinical significance of mitophagy-related genes in hepatocellular carcinoma
por: Xu, Wei, et al.
Publicado: (2022)

m(6)A Methyltransferase METTL14-Mediated Upregulation of Cytidine Deaminase Promoting Gemcitabine Resistance in Pancreatic Cancer
por: Zhang, Congjun, et al.
Publicado: (2021)

Identification of gene signatures related to hypoxia and angiogenesis in pancreatic cancer to aid immunotherapy and prognosis
por: Li, Xiushen, et al.
Publicado: (2023)

A novel gene signature for prognosis prediction and chemotherapy response in patients with pancreatic cancer
por: Lin, Hongcao, et al.
Publicado: (2021)

Identification of an autophagy-related gene signature for predicting prognosis and immune activity in pancreatic adenocarcinoma
por: Deng, Jiang, et al.
Publicado: (2022)

Cathepsin D Expression and Gemcitabine Resistance in Pancreatic Cancer
por: Mahajan, Ujjwal M, et al.
Publicado: (2019)

Identification of an extracellular vesicle-related gene signature in the prediction of pancreatic cancer clinical prognosis
por: Xu, Dafeng, et al.
Publicado: (2020)

Identification of Ferroptosis-Related Gene Prognostic Signature and HSF1 for Reversing Doxorubicin and Gemcitabine Resistance in Uterine Carcinosarcoma
por: Han, Shuxia, et al.
Publicado: (2022)

Digoxin sensitizes gemcitabine-resistant pancreatic cancer cells to gemcitabine via inhibiting Nrf2 signaling pathway
por: Zhou, Yunjiang, et al.
Publicado: (2019)

Association of mucin family members with prognostic significance in pancreatic cancer patients: A meta-analysis
por: Xu, Wei, et al.
Publicado: (2022)

Gene signature for prognosis in comparison of pancreatic cancer patients with diabetes and non-diabetes
por: Yang, Mingjun, et al.
Publicado: (2020)

A pyroptosis-related gene signature for prognosis and immune microenvironment of pancreatic cancer
por: Tao, Sifan, et al.
Publicado: (2022)

Construction and validation of an aging-related gene signature predicting the prognosis of pancreatic cancer
por: Wang, Dengchuan, et al.
Publicado: (2023)

An integrated autophagy-related gene signature predicts prognosis in human endometrial Cancer
por: Zhang, Jun, et al.
Publicado: (2020)

Identification of an immune-related gene-based signature to predict prognosis of patients with gastric cancer
por: Qiu, Xiang-Ting, et al.
Publicado: (2020)

Systematic exploration of the underlying mechanism of gemcitabine resistance in pancreatic adenocarcinoma
por: Liu, Kaidong, et al.
Publicado: (2022)

Establishment and characterization of the gemcitabine-resistant human pancreatic cancer cell line SW1990/gemcitabine
por: Yu, Yue, et al.
Publicado: (2019)

Suppression of IL-6 Gene by shRNA Augments Gemcitabine Chemosensitization in Pancreatic Adenocarcinoma Cells
por: Xing, Hai-Bo, et al.
Publicado: (2018)

Correction: Clusterin confers gemcitabine resistance in pancreatic cancer
por: Chen, Qingfeng, et al.
Publicado: (2013)

Bioinformatics analysis of prognosis and immune microenvironment of immunological cell death-related gemcitabine-resistance genes in bladder cancer
por: Liu, Chao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1fe5hnhltuv979tsohi0oushqi